Research Capital Corporation

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placement offering of its units. Under the offering, Innocan issued 4,005,408 units at $0.30 per unit for aggregate gross proceeds of $1,201,622. The company...

Delta 9 Cannabis Inc. (OTCQX: DLTNF) (TSX DN) has entered into an agreement with Research Capital Corporation as sole agent and sole bookrunner, in connection with an overnight marketed public offering of units of the company at an indicative price of $0.22 per unit, priced in the context of the...

Sugarbud Craft Growers Corp. (OTCQB: SBUDF) (TSXV:SUGR) has entered into an agreement with Research Capital Corporation, acting as sole agent and sole bookrunner, in connection with a marketed public offering of convertible debenture units at a price of $1,000 per debenture unit for aggregate...

CBD company HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB: CBDHF) (FWB:8OO) plans to raise up to $3.0 million via brokered private placement offering led by Research Capital Corporation. Under the offering, the company will offer up to 3,000 convertible debenture units at the issue price of $1,000...